G. Bernhardt

1.3k total citations
29 papers, 947 citations indexed

About

G. Bernhardt is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Oncology. According to data from OpenAlex, G. Bernhardt has authored 29 papers receiving a total of 947 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 7 papers in Cellular and Molecular Neuroscience and 6 papers in Oncology. Recurrent topics in G. Bernhardt's work include Receptor Mechanisms and Signaling (8 papers), Mast cells and histamine (4 papers) and Neuropeptides and Animal Physiology (3 papers). G. Bernhardt is often cited by papers focused on Receptor Mechanisms and Signaling (8 papers), Mast cells and histamine (4 papers) and Neuropeptides and Animal Physiology (3 papers). G. Bernhardt collaborates with scholars based in Germany, Switzerland and Japan. G. Bernhardt's co-authors include Armin Buschauer, Karl O. Stetter, Rainer Jaenicke, Henri Brunner, Christian Lottner, Ruth Knuechel, Stefanie Bauer, Julia Kowal, Ioannis Manolaridis and Nicholas M. I. Taylor and has published in prestigious journals such as Applied and Environmental Microbiology, International Journal of Molecular Sciences and Journal of Controlled Release.

In The Last Decade

G. Bernhardt

28 papers receiving 925 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G. Bernhardt Germany 17 461 316 135 118 111 29 947
Massimo De Paoli Italy 23 1.1k 2.5× 382 1.2× 186 1.4× 69 0.6× 94 0.8× 54 2.1k
Claudia A. Lipschultz United States 22 1.2k 2.6× 314 1.0× 108 0.8× 98 0.8× 74 0.7× 32 1.9k
Erica Baker Australia 28 663 1.4× 457 1.4× 57 0.4× 53 0.4× 42 0.4× 61 2.2k
Ling Yang China 22 532 1.2× 103 0.3× 203 1.5× 149 1.3× 55 0.5× 48 1.0k
Alison K. Holzer United States 17 776 1.7× 1.4k 4.4× 102 0.8× 80 0.7× 44 0.4× 20 2.3k
Andreas Faust Germany 25 565 1.2× 395 1.3× 135 1.0× 223 1.9× 62 0.6× 70 1.7k
Ilse Novak‐Hofer Switzerland 27 989 2.1× 438 1.4× 100 0.7× 38 0.3× 229 2.1× 64 2.0k
Robert H. Newman United States 18 839 1.8× 126 0.4× 86 0.6× 73 0.6× 108 1.0× 57 1.2k
Katsuhiro Tamura Japan 20 371 0.8× 266 0.8× 129 1.0× 55 0.5× 52 0.5× 145 1.2k
Samuel D. Bernal United States 21 1.2k 2.5× 480 1.5× 103 0.8× 178 1.5× 83 0.7× 51 2.1k

Countries citing papers authored by G. Bernhardt

Since Specialization
Citations

This map shows the geographic impact of G. Bernhardt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Bernhardt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Bernhardt more than expected).

Fields of papers citing papers by G. Bernhardt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Bernhardt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Bernhardt. The network helps show where G. Bernhardt may publish in the future.

Co-authorship network of co-authors of G. Bernhardt

This figure shows the co-authorship network connecting the top 25 collaborators of G. Bernhardt. A scholar is included among the top collaborators of G. Bernhardt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Bernhardt. G. Bernhardt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Inoue, Asuka, et al.. (2021). Label-Free Investigations on the G Protein Dependent Signaling Pathways of Histamine Receptors. International Journal of Molecular Sciences. 22(18). 9739–9739. 11 indexed citations
2.
Gergs, Ulrich, G. Bernhardt, Igor Buchwalow, et al.. (2019). Initial Characterization of Transgenic Mice Overexpressing Human Histamine H2 Receptors. Journal of Pharmacology and Experimental Therapeutics. 369(1). 129–141. 42 indexed citations
3.
Stolwijk, Judith A., G. Bernhardt, Armin Buschauer, et al.. (2019). Increasing the throughput of label-free cell assays to study the activation of G-protein-coupled receptors by using a serial agonist exposure protocol. Integrative Biology. 11(3). 99–108. 3 indexed citations
4.
Jackson, Scott M., Ioannis Manolaridis, Julia Kowal, et al.. (2018). Structural basis of small-molecule inhibition of human multidrug transporter ABCG2. Nature Structural & Molecular Biology. 25(4). 333–340. 260 indexed citations
5.
Frings‐Meuthen, Petra, et al.. (2018). The negative effect of unloading exceeds the bone-sparing effect of alkaline supplementation: a bed rest study. Osteoporosis International. 30(2). 431–439. 5 indexed citations
6.
Lieb, Spencer, Timo Littmann, Miho Tanaka, et al.. (2016). Label-free versus conventional cellular assays: Functional investigations on the human histamine H1 receptor. Pharmacological Research. 114. 13–26. 21 indexed citations
7.
Lieb, Spencer, et al.. (2016). Label-free analysis of GPCR-stimulation: The critical impact of cell adhesion. Pharmacological Research. 108. 65–74. 25 indexed citations
8.
Beermann, Silke, G. Bernhardt, Roland Seifert, Armin Buschauer, & Detlef Neumann. (2015). Histamine H1- and H4-receptor signaling cooperatively regulate MAPK activation. Biochemical Pharmacology. 98(3). 432–439. 24 indexed citations
9.
Huber, Stefan A., et al.. (2014). Stabilities of neutral and basic esters of bendamustine in plasma compared to the parent compound: Kinetic investigations by HPLC. Journal of Pharmaceutical and Biomedical Analysis. 104. 137–143. 12 indexed citations
10.
Wifling, David, et al.. (2014). Molecular determinants for the high constitutive activity of the human histamineH4receptor: functional studies on orthologues and mutants. British Journal of Pharmacology. 172(3). 785–798. 29 indexed citations
11.
Bernhardt, G., et al.. (2007). Kinetics of Hyal-1 and PH-20 hyaluronidases: Comparison of minimal substrates and analysis of the transglycosylation reaction. Glycobiology. 17(9). 963–971. 38 indexed citations
12.
Dai, Jisen, Jinlong Jian, Maarten C. Bosland, et al.. (2007). Roles of hormone replacement therapy and iron in proliferation of breast epithelial cells with different estrogen and progesterone receptor status. The Breast. 17(2). 172–179. 36 indexed citations
13.
Lottner, Christian, Ruth Knuechel, G. Bernhardt, & Henri Brunner. (2004). Distribution and subcellular localization of a water-soluble hematoporphyrin–platinum(II) complex in human bladder cancer cells. Cancer Letters. 215(2). 167–177. 55 indexed citations
14.
Lottner, Christian, Ruth Knuechel, G. Bernhardt, & Henri Brunner. (2003). Combined chemotherapeutic and photodynamic treatment on human bladder cells by hematoporphyrin–platinum(II) conjugates. Cancer Letters. 203(2). 171–180. 61 indexed citations
15.
Spruß, Thilo, et al.. (2002). Efficacy of BCNU and paclitaxel loaded subcutaneous implants in the interstitial chemotherapy of U-87 MG human glioblastoma xenografts. International Journal of Pharmaceutics. 238(1-2). 111–121. 30 indexed citations
16.
Magni, Elisabetta, A. Gazzaniga, Thilo Spruß, et al.. (2001). Programmable biodegradable implants. Journal of Controlled Release. 73(1). 75–88. 23 indexed citations
17.
18.
Hofmann, Manuel, et al.. (1994). In vitro activity of immunoconjugates between cisplatin and an anti-CA125 monoclonal antibody on ovarian cancer cell lines. Cell Biophysics. 24-25(1-3). 163–173. 5 indexed citations
19.
Bernhardt, G., et al.. (1993). Dichlorobis(cycloalkylamine)platinum(II) complexes structure activity relationship on the human MDA-MB-231 breast cancer cell line. Monatshefte für Chemie - Chemical Monthly. 124(5). 587–604. 5 indexed citations
20.
Bernhardt, G., et al.. (1991). D-17446. Drugs of the Future. 16(10). 899–899. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Massimo De Paoli Breakdown of academic impact, for papers by Claudia A. Lipschultz Breakdown of academic impact, for papers by Erica Baker Breakdown of academic impact, for papers by Ling Yang Breakdown of academic impact, for papers by Alison K. Holzer Breakdown of academic impact, for papers by Andreas Faust Breakdown of academic impact, for papers by Ilse Novak‐Hofer Breakdown of academic impact, for papers by Robert H. Newman Breakdown of academic impact, for papers by Katsuhiro Tamura Breakdown of academic impact, for papers by Samuel D. Bernal
Rankless by CCL
2026